Gilberto Lopes

12.9k citations
227 papers · 3.9k · 1 hit paper · h-index 35

Impact in

  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Research Studies
    • Pancreatic and Hepatic Oncology Research
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

Gilberto Lopes

210 papers receiving 3.8k citations

Gilberto Lopes's Hit Papers

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non–Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study 2022 · 169 citations
1690+1+2Years since publication50100150

Peers

Gilberto Lopes
Comparison fields: 5 of 138
  • Oncology 1.7k
  • Pulmonary and Respiratory Medicine 1.1k
  • Cancer Research 417
  • Hepatology 99
  • Immunology 268
Replace Paul G. Kluetz with:
Paul G. Kluetz United States
Kirsten B. Goldberg United States
Francesco Perrone Italy
Francisco Vera-Badillo Canada
Andrew Lake United States
Julia A. Beaver United States
Pilar Garrido Spain
Narjust Duma United States
Scott Berry Canada
H. Au Canada
Gilberto Lopes relative to Paul G. Kluetz United States Paul G. Kluetz's profile →
Citations per field
00.5×1.5×
Paul G. Kluetz · 1×
Citations per year

Countries citing papers authored by Gilberto Lopes

Since Specialization
Citations

This map shows the geographic impact of Gilberto Lopes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilberto Lopes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilberto Lopes more than expected).

Fields of papers citing papers by Gilberto Lopes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilberto Lopes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilberto Lopes. The network helps show where Gilberto Lopes may publish in the future.

Co-authors

The 25 scholars most cited alongside Gilberto Lopes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gilberto Lopes Line = papers co-authored together Gilberto Lopes links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 227 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non–Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study
Hit paper breakdown →
2022169
2 2017158
3 2016123
4 2008110
5 2018100
6 201287
7 201979
8 201377
9 201674
10 202073
11 201572
12 201071
13 201169
14 201868
15 201467
16 202265
17 201965
18 201162
19 201962
20 201262

About Gilberto Lopes

Gilberto Lopes is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Economics and Econometrics, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 227 papers that have together received 3.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (57 papers), Cancer Immunotherapy and Biomarkers (31 papers), Economic and Financial Impacts of Cancer (28 papers), Colorectal Cancer Treatments and Studies (22 papers), Health Systems, Economic Evaluations, Quality of Life (20 papers), Cancer Genomics and Diagnostics (20 papers), Cancer Treatment and Pharmacology (16 papers) and Pharmaceutical Economics and Policy (15 papers). The work is most often cited by research in Oncology (1.7k citations), Pulmonary and Respiratory Medicine (1.1k citations), Cancer Research (417 citations), Hepatology (99 citations) and Immunology (268 citations). Gilberto Lopes has collaborated with scholars based in United States, Brazil and Singapore. Frequent co-authors include Benjamin Haaland, Pedro Nazareth Aguiar, Pui San Tan, Alberto J. Montero, Hakaru Tadokoro, Ramon Andrade de Mello, Geoffrey Y. Ku, Stefan Glück, Carlos H. Barrios and Gilberto de Castro. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Breast Cancer Research and Treatment and JCO Global Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact